You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
传美国招揽南非及拉丁美洲科学家於当地展开大型疫苗临床测试
阿思达克 08-14 12:10
《路透社》引述消息人士报道,美国政府正为「曲率极速行动」(Operation Warp Speed)大型疫苗研发计划招揽南非及拉丁美洲科学家,於当地进行新冠病毒疫苗临床测试,以换取这些国家可以较易获得疫苗。

据悉南非、墨西哥、巴西、秘鲁及阿根廷的研究人员正在讨论加入该计划,於下月开始对强生的疫苗展开大规模临床测试。

除强生的疫苗外,美国政府还与Moderna、Novavax及阿斯利康(AstraZeneca)合作进行大规模的第三阶段临床测试。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account